SPAC DMAA shareholders approve extension to April 2027; ~28% of shares redeemed for $99.3M

Drugs Made In America Acquisition Corp.

Extension proposal approved: 18,906,281 for, 4,892,646 against, 0 abstain.
Combination period extended up to 12 months to April 29, 2027 with monthly deposits of ~$300k.
Redemption of 9,440,230 shares at ~$10.52/share, removing $99,336,016.67 from trust account.
Post-redemption shares outstanding: 24,276,913 (13,559,770 from IPO).
Board approved initial one-month extension to May 29, 2026.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Drugs Made In America Acquisition Corp.: Amended charter to extend business combination deadline from April 29, 2026 to April 29, 2027, with up to twelve monthly extensions subject to sponsor deposit (effective 2026-04-27).

Change: charter amendment
Effective: 2026-04-27

Exact text from the filing

to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “ Existing Charter ”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “ Extension Amendment ”) which reflects the extension of the date by which the Company must consummate a business combination (the “ Combination Period ”) up to twelve (12) times from April 29, 2026 (the “ Termination Date ”) to April 29, 2027, each by an additional one (1) month

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Drugs Made In America Acquisition Corp. shareholders approved Extension Proposal.

Outcome: passed

Exact text from the filing

The Extension Proposal was approved by special resolution of the Company’s shareholders, and received the following votes: FOR AGAINST ABSTAIN 18,906,281 4,892,646 0

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Drugs Made In America Acquisition Corp. filing history →

Source: SEC EDGAR

accession 0001213900-26-051018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.